SCHEMBL31322121

SCHEMBL31322121

Cc1ccc(S(=O)(=O)CC2CN(CO)c3ccccc32)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.41
ALDH1A1 P00352 6/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
NR2F2 P24468 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
RECQL P46063 1/20 0.38
TERT O14746 1/20 0.36
TP53 P04637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31322158 0.78 HCRTR2 (0.37) ALDH1A1MEN1KMT2ALMNACYP2C19
SCHEMBL31322118 0.75 CCR5 (0.39)
SCHEMBL6604130 0.68 HTR6 (0.43) ALDH1A1MEN1KMT2ALMNAHTT
SCHEMBL6601432 0.68 HTR6 (0.43) ALDH1A1MEN1KMT2ALMNAHTT
SCHEMBL31322148 0.65 ESR1 (0.47)
SCHEMBL1782820 0.65 CRBN (0.55) CRBNALDH1A1MEN1KMT2AHSD17B10
SCHEMBL31322144 0.64 HTR6 (0.48) MEN1KMT2A
SCHEMBL31322157 0.64 L3MBTL1 (0.44) ALDH1A1MEN1KMT2A
SCHEMBL6600655 0.63 LMNA (0.43) ALDH1A1MEN1KMT2ALMNAHTT
SCHEMBL4846711 0.62 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ARECQLTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP claimed
EP-4483866-A1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF CANCER Makrolife Biotech GmbH (DE) 2025-01-01 EP disclosed